Allworth Financial’s Avadel Pharmaceuticals AVDL Stock Holding History

Allworth Financial’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116	Closed	-$2.5K	–	5194
2025 Q4	$2.5K	Hold	116	–	–	﹤0.01%	4034
2025 Q3	$1.77K	Hold	116	–	–	﹤0.01%	4064
2025 Q2	$1.03K	Buy	116 +87	+300%	+$764	﹤0.01%	3956
2025 Q1	$250	Buy	+29	New	+$243	﹤0.01%	3829

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Allworth Financial's AVDL Position: Q1 2026 in Review

Allworth Financial sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 116 shares — an estimated $2.5K sold.

Allworth Financial first reported a position in AVDL in Q1 2025 and held it in 4 quarters. The position peaked at $2.5K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Allworth Financial reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Allworth Financial sold 116 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.5K.
Allworth Financial first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 4 quarters.
Allworth Financial's Avadel Pharmaceuticals position peaked at $2.5K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.